Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v4-EN
Language English English
Date Updated 2020-09-09 2020-04-21
Drug Identification Number 02386933 02386933
Brand name TRANEXAMIC ACID INJECTION BP TRANEXAMIC ACID INJECTION BP
Common or Proper name TRANEXAMIC ACID INJECTION BP TRANEXAMIC ACID INJECTION BP
Company Name STERIMAX INC STERIMAX INC
Ingredients TRANEXAMIC ACID TRANEXAMIC ACID
Strength(s) 100MG 100MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS - 10 ML 10 VIALS - 10 ML
ATC code B02AA B02AA
ATC description ANTIFIBRINOLYTICS ANTIFIBRINOLYTICS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-04-20 2020-04-20
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments